default author photo

Markus Maeurer

Champalimaud Foundation - Champalimaud Center for the Unknown

Avenida Brasília

Lisboa, 1400-038

Portugal

SCHOLARLY PAPERS

2

DOWNLOADS

163

TOTAL CITATIONS

15

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Human Umbilical Cord-Derived Mesenchymal Stem Cell Therapy in COVID-19 Patients: A Phase 1 Clinical Trial

Number of pages: 32 Posted: 14 Jul 2020
Fan-Ping Meng, Ruo-Nan Xu, Siyu Wang, Zhe Xu, Chao Zhang, Yuanyuan Li, Tao Yang, Lei Shi, Junliang Fu, Tianjun Jiang, Lei Huang, Peng Zhao, Xin Yuan, Xing Fan, Ji-Yuan Zhang, Jinwen Song, Dawei Zhang, Yanmei Jiao, Limin Liu, Chunbao Zhou, Markus Maeurer, Alimuddin Zumla, Ming Shi and Fu-Sheng Wang
Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, 302 Military Hospital of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Champalimaud Foundation - Champalimaud Center for the Unknown, University College London - National Institute for Health and Care Research Biomedical Research Centre, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases and Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases
Downloads 104 (674,591)
Citation 8

Abstract:

Loading...

2.

COVID-19 Disease - Temporal Analyses of Complete Blood Count Parameters Over Course of Illness, and Relationship to Patient Demographics and Management Outcomes in Survivors and Non-Survivors: A Longitudinal Descriptive Cohort Study

Number of pages: 28 Posted: 25 Sep 2020
Simone Lanini, Chiara Montaldo, Emanuele Nicastri, Francesco Vairo, Chiara Agrati, Nicola Petrosillo, Paola Scognamiglio, Andrea Antinori, Vincenzo Puro, Antonino Di Caro, Gabriella De Carli, Assunta Navarra, Alessandro Agresta, Claudia Cimaglia, Fabrizio Palmieri, Gianpiero D’Offizi, Luisa Marchioni, Claudia Cimaglia, Fabrizio Palmieri, Gianpiero D’Offizi, Luisa Marchioni, Gary Pignac Kobinger, Markus Maeurer, Enrico Girardi, Maria Rosaria Capobianchi, Alimuddin Zumla, Franco Locatelli and Giuseppe Ippolito
Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Clinical Division of Infectious Diseases, National Institute for Infectious Diseases, Lazzaro Spallanzani, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Independent, Independent, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - HIV/AIDS Department, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Risk Management, Independent, Independent, Independent, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Independent, Independent, Independent, Independent, Independent, Independent, Independent, Independent, Independent, Champalimaud Foundation - Champalimaud Center for the Unknown, Independent, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, University College London - National Institute for Health and Care Research Biomedical Research Centre, Bambino Gesù Children's Hospital - Department of Pediatric Hematology and Oncology and Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI
Downloads 59 (980,173)
Citation 7

Abstract:

Loading...

SARS-CoV-2; COVID-19; haematology; full blood counts; biomarkers; prognosis